Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinae Kim

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Molecules and Cells|January 10, 2019
Crystal Structure of Histidine Triad Nucleotide-Binding Protein from the Pathogenic Fungus <i>Candida albicans</i>Ahjin Jung, Ji-Sook Yun, Shinae Kim, et al.
Biochemical and Biophysical Research Communications|November 26, 2018
Identification of LEM-14 inhibitor of the oncoprotein NSD2Yunpeng Shen, Masayo Morishita, Doohyun Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2014
Synthesis and biological evaluation of picolinamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)Je Ho Ryu, Shinae Kim, Hye Young Han, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2015
Synthesis and optimization of picolinamide derivatives as a novel class of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitorsJe Ho Ryu, Shinae Kim, Jung A Lee, et al.
Bioorganic & Medicinal Chemistry|July 10, 2010
Identification of a potent and noncytotoxic inhibitor of melanin productionSoonho Hwang, Sang Yoon Choi, Jin Hee Lee, et al.
Clinical Pharmacology and Therapeutics|April 17, 2026
Comparative Use Human Factors Study of a Manual vs. A Partially Automated Pen Injector for GLP-1 Receptor Agonist DeliveryKarthika Natarajan, Andrew Clerman, Jennifer Soosaar, et al.
European Journal of Pharmacology|November 1, 2015
A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice modelsHyunhee Oh, Kyeong-Hoon Jeong, Hye Young Han, et al.
NPJ Biofilms and Microbiomes|April 25, 2025
Toxic cultures: e-cigarettes and the oral microbial exposomeMichelle Lee-Scott Beverly, Prem Prashant Chaudhary, Shareef Majid Dabdoub, et al.
Plos One|July 19, 2012
Chitooligosaccharide induces mitochondrial biogenesis and increases exercise endurance through the activation of Sirt1 and AMPK in ratsHyun Woo Jeong, Si Young Cho, Shinae Kim, et al.
Journal of Medicinal Chemistry|November 1, 2016
Discovery of 2-((R)-4-(2-Fluoro-4-(methylsulfonyl)phenyl)-2-methylpiperazin-1-yl)-N-((1R,2s,3S,5S,7S)-5-hydroxyadamantan-2-yl)pyrimidine-4-carboxamide (SKI2852): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)Je Ho Ryu, Jung A Lee, Shinae Kim, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecules and Cells|January 10, 2019
Crystal Structure of Histidine Triad Nucleotide-Binding Protein from the Pathogenic Fungus <i>Candida albicans</i>Ahjin Jung, Ji-Sook Yun, Shinae Kim, et al.
Biochemical and Biophysical Research Communications|November 26, 2018
Identification of LEM-14 inhibitor of the oncoprotein NSD2Yunpeng Shen, Masayo Morishita, Doohyun Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2014
Synthesis and biological evaluation of picolinamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)Je Ho Ryu, Shinae Kim, Hye Young Han, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2015
Synthesis and optimization of picolinamide derivatives as a novel class of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitorsJe Ho Ryu, Shinae Kim, Jung A Lee, et al.
Bioorganic & Medicinal Chemistry|July 10, 2010
Identification of a potent and noncytotoxic inhibitor of melanin productionSoonho Hwang, Sang Yoon Choi, Jin Hee Lee, et al.
Clinical Pharmacology and Therapeutics|April 17, 2026
Comparative Use Human Factors Study of a Manual vs. A Partially Automated Pen Injector for GLP-1 Receptor Agonist DeliveryKarthika Natarajan, Andrew Clerman, Jennifer Soosaar, et al.
European Journal of Pharmacology|November 1, 2015
A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice modelsHyunhee Oh, Kyeong-Hoon Jeong, Hye Young Han, et al.
NPJ Biofilms and Microbiomes|April 25, 2025
Toxic cultures: e-cigarettes and the oral microbial exposomeMichelle Lee-Scott Beverly, Prem Prashant Chaudhary, Shareef Majid Dabdoub, et al.
Plos One|July 19, 2012
Chitooligosaccharide induces mitochondrial biogenesis and increases exercise endurance through the activation of Sirt1 and AMPK in ratsHyun Woo Jeong, Si Young Cho, Shinae Kim, et al.
Journal of Medicinal Chemistry|November 1, 2016
Discovery of 2-((R)-4-(2-Fluoro-4-(methylsulfonyl)phenyl)-2-methylpiperazin-1-yl)-N-((1R,2s,3S,5S,7S)-5-hydroxyadamantan-2-yl)pyrimidine-4-carboxamide (SKI2852): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)Je Ho Ryu, Jung A Lee, Shinae Kim, et al.
Pageof 3